# Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

> **NCT06444763** · PHASE3 · COMPLETED · sponsor: **RDC Clinical Pty Ltd** · enrollment: 97 (actual)

## Conditions studied

- Chronic Inflammation
- Mobility
- Muscle Pain
- Joint Pain

## Interventions

- **DRUG:** Maolactin
- **DRUG:** Maltodextrin

## Key facts

- **NCT ID:** NCT06444763
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-27
- **Primary completion:** 2026-02-16
- **Final completion:** 2026-02-16
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06444763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06444763, "Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06444763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*